We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$13.5B
AUM Growth
+$829M
(+6.5%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-18.66%
Top 10 Holdings %
Top 10 Hldgs %
16.93%
Holding
671
New
60
Increased
214
Reduced
141
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$58.5M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$31.2M |
| 3 |
Apple
AAPL
|
+$24.7M |
| 4 |
NCR Voyix
VYX
|
+$23.5M |
| 5 |
Amgen
AMGN
|
+$22.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$55.5M |
| 2 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$53.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$48.2M |
| 4 |
EXCU
Exelon Corporation
EXCU
|
+$46.4M |
| 5 |
Costco
COST
|
+$37.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11% |
| 2 | Technology | 9.33% |
| 3 | Healthcare | 8.36% |
| 4 | Industrials | 6.68% |
| 5 | Communication Services | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cintas
CTAS
$82.4B
| $17.4M | 0.13% |
553,056
-18,192
| -3% | -$566K |
|
152
Altria Group
MO
$122B
| $17.4M | 0.13% |
232,975
-50,737
| -18% | -$3.71M |
|
153
Bristol-Myers Squibb
BMY
$127B
| $17.2M | 0.13% |
308,825
+10,369
| +3% | +$564K |
|
154
Kroger
KR
$34.8B
| $17M | 0.13% |
729,782
-16,589
| -2% | -$471K |
|
155
L3Harris
LHX
$55.9B
| $16.9M | 0.13% |
155,323
-5,109
| -3% | -$563K |
|
156
Cboe Global Markets
CBOE
$29.8B
| $16.8M | 0.12% |
183,392
-159,801
| -47% | -$13.6M |
|
157
Mohawk Industries
MHK
$6.9B
| $16.6M | 0.12% |
68,782
-1,142
| -2% | -$269K |
|
|
DD
158
DELISTED
Du Pont De Nemours E I
DD
| $16.6M | 0.12% |
205,351
+1,870
| +0.9% | +$149K |
|
159
Abbott
ABT
$180B
| $16.5M | 0.12% |
338,983
+4,678
| +1% | +$212K |
|
160
BP
BP
$113B
| $16.5M | 0.12% |
535,784
-8,930
| -2% | -$278K |
|
161
Microchip Technology
MCHP
$42.8B
| $16.3M | 0.12% |
421,714
-7,046
| -2% | -$277K |
|
162
CALL
Oracle
ORCL
$331B
| $16.3M | 0.12% |
+324,300
| New | +$14.8M |
|
163
Whirlpool
WHR
$2.42B
| $16.2M | 0.12% |
84,391
+2,758
| +3% | +$505K |
|
164
Vulcan Materials
VMC
$36.3B
| $16.1M | 0.12% |
126,854
-4,180
| -3% | -$525K |
|
165
Tenaris
TS
$29.1B
| $16M | 0.12% |
514,008
+88,154
| +21% | +$2.78M |
|
|
HOLX
166
DELISTED
Hologic
HOLX
| $15.9M | 0.12% |
349,745
-150,159
| -30% | -$6.63M |
|
167
TransUnion
TRU
$14.8B
| $15.9M | 0.12% |
366,124
-38,405
| -9% | -$1.59M |
|
|
TSS
168
DELISTED
Total System Services, Inc.
TSS
| $15.2M | 0.11% |
261,352
-28,331
| -10% | -$1.62M |
|
|
SWP
169
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
| $15.1M | 0.11% |
+137,990
| New | +$14.7M |
|
170
Incyte
INCY
$23.5B
| $14.2M | 0.11% |
113,132
+30,990
| +38% | +$3.94M |
|
171
Eagle Materials
EXP
$6.6B
| $14.2M | 0.11% |
154,019
-26,839
| -15% | -$2.58M |
|
172
Parker-Hannifin
PH
$125B
| $14.2M | 0.11% |
89,051
-2,648
| -3% | -$420K |
|
173
AbbVie
ABBV
$458B
| $14.2M | 0.11% |
196,076
-44,653
| -19% | -$3M |
|
|
VRTSP
174
DELISTED
Virtus Investment Partners, Inc. 7.25% Series D Mandatory Convertible Preferred Stock
VRTSP
| $14.2M | 0.1% |
140,000
| – | – |
|
175
IBM
IBM
$202B
| $13.9M | 0.1% |
94,411
-19,048
| -17% | -$2.87M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Calamos Advisors held 671 positions worth $13.5B, up 6.5% from $12.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Calamos Advisors withdrew a net $2.52B in Q2 2017, closing 65 positions and reducing 141 holdings. Its most notable exit was American Tower Corporation, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6 worth $59.5M.
- Calamos Advisors's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 1,086,994 shares worth $59.5M.
- Calamos Advisors added most to Alexion Pharmaceuticals in Q2 2017, an estimated $31.2M increase.
- Calamos Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $55.5M.
- Calamos Advisors fully exited American Tower Corporation in Q2 2017, selling an estimated $53.6M.
- Calamos Advisors's ten largest holdings make up 17% of its $13.5B portfolio in Q2 2017.
- Calamos Advisors opened 60 new positions and closed 65 in Q2 2017.
- Calamos Advisors's portfolio value rose 6.5% quarter-over-quarter to $13.5B.
Based on Calamos Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.